Statistics

Total Visits

Views
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL(legacy) 161
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL(legacy) 77

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL 1 1 4 2 4 3 2

File Downloads

Views

Top Country Views

Views
United States 72
Australia 37
China 8
France 8
Netherlands 8
Vietnam 8
Germany 6
Ireland 4
Spain 2
Turkey 1

Top City Views

Views
Ashburn 31
Kaleen 30
Fairfield 8
Hanoi 8
Rotterdam 8
Dublin 4
Beijing 3
Boardman 3
Cambridge 3
Madrid 2